Suppr超能文献

鉴定上皮性卵巢癌中稳定表达的参考 microRNAs。

Identification of Stably Expressed Reference microRNAs in Epithelial Ovarian Cancer.

机构信息

Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

Department of Gynaecology, Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

出版信息

In Vivo. 2022 May-Jun;36(3):1059-1066. doi: 10.21873/invivo.12803.

Abstract

BACKGROUND/AIM: MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression and have been associated with the development of various cancers, including epithelial ovarian cancer (EOC). Accurate quantification of miRNA levels is important for determining their role in tumorigenesis and as biomarkers. Currently, U6 is widely used as a normalization control when investigating miRNAs in EOC; however, its variable expression across cancers has been reported. As only a few studies have been published to date on the identification of endogenous miRNA controls in EOC, our aim was to identify stable miRNAs based on global microarray profiling of 197 EOC patients and verify their stability in external datasets.

MATERIALS AND METHODS

We collected miRNA-microarray data from four datasets: the in-house "Pelvic Mass", and three public datasets with primary EOC patients: The Cancer Genome Atlas, GSE47841, and GSE73581. The expression stability of endogenous control candidates was evaluated by their coefficient of variation.

RESULTS

All miRNA results in the used cohorts were produced by either Affymetrix or Agilent technologies, which show similar intra-platform patterns. Nonetheless, a clear difference in a cross-platform comparison was observed. We identified hsa-miR-92b-5p and hsa-miR-106b-3p as stable candidates shared between four datasets. Moreover, we investigated the stability performance of eight miRNAs that have been previously reported as stable endogenous controls in EOC and various performance was observed in four datasets.

CONCLUSION

The selection of suitable endogenous miRNA normalization controls in EOC remains to be resolved, as variability in miRNA performance between platforms might have a crucial impact on the biological interpretation of data.

摘要

背景/目的:微小 RNA(miRNA)是一种小的非编码 RNA 分子,可调节基因表达,与多种癌症的发生有关,包括上皮性卵巢癌(EOC)。miRNA 水平的准确定量对于确定其在肿瘤发生中的作用和作为生物标志物非常重要。目前,在研究 EOC 中的 miRNA 时,U6 广泛用作归一化对照;然而,已有报道称其在癌症中表达可变。由于迄今为止只有少数研究发表了关于在 EOC 中鉴定内源性 miRNA 对照的研究,我们的目的是基于 197 名 EOC 患者的全局微阵列分析来鉴定稳定的 miRNA,并在外部数据集验证其稳定性。

材料和方法

我们从四个数据集收集 miRNA 微阵列数据:内部“盆腔肿块”和三个具有原发性 EOC 患者的公共数据集:癌症基因组图谱、GSE47841 和 GSE73581。通过其变异系数评估内源性对照候选物的表达稳定性。

结果

使用队列中的所有 miRNA 结果均由 Affymetrix 或 Agilent 技术产生,这两种技术显示出相似的平台内模式。尽管如此,在平台间比较中仍观察到明显差异。我们确定 hsa-miR-92b-5p 和 hsa-miR-106b-3p 是四个数据集之间共享的稳定候选物。此外,我们研究了先前报道为 EOC 和各种性能在四个数据集内稳定的内源性控制的 8 个 miRNA 的稳定性表现。

结论

EOC 中合适的内源性 miRNA 归一化对照的选择仍有待解决,因为平台之间 miRNA 性能的差异可能对数据的生物学解释产生至关重要的影响。

相似文献

本文引用的文献

2
Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.循环微小RNA-141在上皮性卵巢癌中的表达
Malays J Med Sci. 2020 Dec;27(6):27-38. doi: 10.21315/mjms2020.27.6.4. Epub 2020 Dec 1.
10
Five serum microRNAs for detection and predicting of ovarian cancer.用于检测和预测卵巢癌的五种血清微小核糖核酸
Eur J Obstet Gynecol Reprod Biol X. 2019 Apr 6;3:100017. doi: 10.1016/j.eurox.2019.100017. eCollection 2019 Jul.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验